NCT04096157View on ClinicalTrials.gov

A Study to Assess Isavuconazole Following a Single Dose of Isavuconazonium Sulfate Intravenous Solution Via Nasogastric (NG) Tube Compared to a Single Dose of Oral Capsules Under Fasting Conditions in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

September 24, 2019

Primary Completion Date

January 16, 2020

Study Completion Date

January 16, 2020

Conditions
Healthy Subjects
Interventions
DRUG

Isavuconazonium sulfate IV

Intravenous (IV) via nasogastric (NG) tube

DRUG

Isavuconazonium sulfate capsules

Oral

Trial Locations (1)

21225

Parexel International, Baltimore

All Listed Sponsors
lead

Astellas Pharma Global Development, Inc.

INDUSTRY

NCT04096157 - A Study to Assess Isavuconazole Following a Single Dose of Isavuconazonium Sulfate Intravenous Solution Via Nasogastric (NG) Tube Compared to a Single Dose of Oral Capsules Under Fasting Conditions in Healthy Participants | Biotech Hunter | Biotech Hunter